Alfarsi, L.H.; El-Ansari, R.; Craze, M.L.; Masisi, B.K.; Mohammed, O.J.; Ellis, I.O.; Rakha, E.A.; Green, A.R.
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 1407.
https://doi.org/10.3390/ijms21041407
AMA Style
Alfarsi LH, El-Ansari R, Craze ML, Masisi BK, Mohammed OJ, Ellis IO, Rakha EA, Green AR.
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer. International Journal of Molecular Sciences. 2020; 21(4):1407.
https://doi.org/10.3390/ijms21041407
Chicago/Turabian Style
Alfarsi, Lutfi H., Rokaya El-Ansari, Madeleine L. Craze, Brendah K. Masisi, Omar J. Mohammed, Ian O. Ellis, Emad A. Rakha, and Andrew R. Green.
2020. "Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer" International Journal of Molecular Sciences 21, no. 4: 1407.
https://doi.org/10.3390/ijms21041407
APA Style
Alfarsi, L. H., El-Ansari, R., Craze, M. L., Masisi, B. K., Mohammed, O. J., Ellis, I. O., Rakha, E. A., & Green, A. R.
(2020). Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer. International Journal of Molecular Sciences, 21(4), 1407.
https://doi.org/10.3390/ijms21041407